Original Article

Bacterial profile and their antimicrobial resistance patterns among patients with community‑acquired pneumonia in southwestern Iran

Abstract

Background and Objectives: Community-acquired pneumonia (CAP) is one of the most common life-threatening infections, occurring in the community or within the first 48 hours of a patient's hospitalization. The present study aimed to investigate the frequency of pathogenic bacteria and their antibiotic resistance pattern in the sputum of patients with community-acquired pneumonia in Yasuj from 2018 to 2019.
Materials and Methods: In the present study, 128 patients with CAP were included. Under aseptic conditions clinical samples including sputum collected from each patient were sent to the Microbiology Laboratory. Specific culture media and biochemical tests were used to identify the bacteria. Antimicrobial resistance patterns of the isolates were examined by disc diffusion. DNA was extracted from sputum using the phenol-chloroform method. The PCR method was used for the molecular detection of bacteria. Data were analyzed using SPSS software version 22 and the chi-square test.
Results: The most common clinical symptoms in patients were sputum (68.8%), fever (64.1%), shortness of breath (60.2%), cough (50.8%), and chest pain (24.2%). A total of 133 bacteria were identified by culture and 117 bacteria by PCR. In the current study, the most prevalent organisms were Streptococcus pneumoniae (24.1%), Hemophilus influenzae (18%), Staphylococcus aureus (13.5%), and Moraxella catarrhalis (11.4%). Antibiogram test showed that most of the Gram-negative bacteria were resistant to levofloxacin (22.6%), rifampin (20.8%) and ceftriaxone (17%), and the highest resistance rate to clindamycin (43.1%), ciprofloxacin (43.1%) and amoxicillin (41.4%) were detected in the Gram-positive bacteria. Cefepime was the most effective antibiotic against Gram negative bacteria.
Conclusion: S. pneumoniae was the most prevalent bacteria identified by culture and PCR methods in patients with CAP, indicating an important role of this bacterium in the pathogenesis of CAP. According to the results, cefepime can be used to treat patients with CAP with Gram-negative bacteria. In the present study, S. pneumoniae, S. aureus, P. aeruginosa, H. influenzae, M. catarrhalis, and K. pneumoniae have been isolated from the CAP patient population with varying frequencies. This is consistent with various studies in different parts of the world.

1. Lupisan S, Suzuki A, Macalalad N, Egos R, Sombrero L, Okamoto M, et al. Etiology and epidemiology of community-acquired pneumonia in adults requiring hospital admission: A prospective study in rural Central Philippines. Int J Infect Dis 2019; 80: 46-53.
2. Shoar S, Musher DM. Etiology of community-acquired pneumonia in adults: a systematic review. Pneumonia (Nathan) 2020; 12: 11.
3. Hassen M, Toma A, Tesfay M, Degafu E, Bekele S, Ayalew F, et al. Radiologic Diagnosis and Hospitalization among Children with Severe Community Acquired Pneumonia: A Prospective Cohort Study. Biomed Res Int 2019; 2019: 10.1155/2019/6202405.
4. Kolditz M, Ewig S. Community-acquired Pneumonia in adults. Dtsch Arztebl Int 2017; 114: 838-848.
5. Jain S, Self WH, Wunderink RG, Fakhran S, Balk R, Bramley AM, et al. Community-acquired Pneumonia requiring hospitalization among U.S. adults. N Engl J Med 2015; 373: 415-427.
6. Myint PK, Kwok CS, Majumdar SR, Eurich DT, Clark AB, España PP, et al. The international community-acquired Pneumonia (CAP) Collaboration Cohort (ICCC) study: rationale, design and description of study cohorts and patients. BMJ Open 2012; 2(3): e001030.
7. Song J-H, Oh WS, Kang C-I, Chung DR, Peck KR, Ko KS, et al. Epidemiology and clinical outcomes of community-acquired pneumonia in adult patients in Asian countries: a prospective study by the Asian network for surveillance of resistant pathogens. Int J Antimicrob Agents 2008; 31: 107-114.
8. Cavallazzi R, Furmanek S, Arnold FW, Beavin LA, Wunderink RG, Niederman MS, et al. The burden of community-acquired pneumonia requiring admission to ICU in the United States. Chest 2020; 158: 1008-1016.
9. Aydoğdu M, Ozyilmaz E, Aksoy H, Gürsel G, Ekim N. Mortality prediction in community-acquired pneumonia requiring mechanical ventilation; values of pneumonia and intensive care unit severity scores. Tuberk Toraks 2010; 58: 25-34.
10. Garin N, Marti C, Scheffler M, Stirnemann J, Prendki V. Computed tomography scan contribution to the diagnosis of community-acquired pneumonia. Curr Opin Pulm Med 2019; 25: 242-248.
11. Ebell MH, Chupp H, Cai X, Bentivegna M, Kearney M. Accuracy of signs and symptoms for the diagnosis of community-acquired Pneumonia: a meta-analysis. Acad Emerg Med 2020; 27: 541-553.
12. Almirall J, Serra-Prat M, Bolíbar I, Balasso V. Risk factors for community-acquired Pneumonia in adults: a systematic review of observational studies. Respiration 2017; 94: 299-311.
13. Muthumbi E, Lowe BS, Muyodi C, Getambu E, Gleeson F, Scott JAG. Risk factors for community-acquired pneumonia among adults in Kenya: a case–control study. Pneumonia (Nathan) 2017; 9: 17.
14. Harrison TR. Medicina interna de Harrison. Medicina interna de Harrison 2017. p. 665.
15. Kumar KJ, Ashok Chowdary KV, Usha HC, Kulkarni M, Manjunath VG. Etiology of community acquired pneumonia among children in India with special reference to atypical pathogens. Lung India 2018; 35: 116-120.
16. Ojuawo OB, Desalu OO, Fawibe AE, Ojuawo AB, Aladesanmi AO, Opeyemi CM, et al. Clinical and microbiological profile of adult inpatients with community acquired pneumonia in Ilorin, North Central, Nigeria. Afr Health Sci 2020; 20: 1655-1668.
17. Musher DM, Roig IL, Cazares G, Stager CE, Logan N, Safar H. Can an etiologic agent be identified in adults who are hospitalized for community-acquired pneumonia: results of a one-year study. J Infect 2013; 67: 11-18.
18. Bartlett JG. Diagnostic tests for agents of community-acquired pneumonia. Clin Infect Dis 2011; 52 Suppl 4: S296-304.
19. Johansson N, Kalin M, Giske CG, Hedlund J. Quantitative detection of Streptococcus pneumoniae from sputum samples with real-time quantitative polymerase chain reaction for etiologic diagnosis of community-acquired pneumonia. Diagn Microbiol Infect Dis 2008; 60: 255-261.
20. Sabz G, Moradi S, Sharifi A, Naghmachi M, Taheripour Sisakht M, Khoramrooz SS. Identification and detection of pathogenic bacteria in adenoid tissue of adenoidectomized children: emergence of Staphylococcus aureus as the most prevalent pathogen. Jundishapur J Microbiol 2020; 13(1): e95445.
21. Askarinia M, Ghaedi M, Manzouri L, Khoramrooz SS, Sharifi A, Ghalamfarsa G, et al. The effect of Cu-BPDCA-Ty on antibacterial activity and the expression of mecA gene in clinical and standard strains of methicillin-resistant Staphylococcus aureus. Jundishapur J Microbiol 2018; 11(3): e60680.
22. Zamani A, Yousefi Mashouf R, Ebrahimzadeh Namvar AM, Alikhani MY. Detection of magA gene in Klebsiella spp. isolated from clinical samples detection of magA. Iran J Basic Med Sci 2013; 16: 173-176.
23. Najafimosleh M, Rashnotaie S, Ghaznavi Rad E, Abtahi H, Taleie G. Designing of the specific DNA primers for detection of the exoA, oprL and algD pathogenicity genes for rapid diagnosis of Pseudomonas aeruginosa. Tehran Univ Med J 2013; 71: 493-501.
24. Batool S, Almaghaslah D, Alqahtani A, Almanasef M, Alasmari M, Vasudevan R, et al. Aetiology and antimicrobial susceptibility pattern of bacterial isolates in community acquired pneumonia patients at Asir region, Saudi Arabia. Int J Clin Pract 2021; 75(2): e13667.
25. El-Sokkary RH, Ramadan RA, El-Shabrawy M, El-Korashi LA, Elhawary A, Embarak S, et al. Community acquired pneumonia among adult patients at an Egyptian university hospital: bacterial etiology, susceptibility profile and evaluation of the response to initial empiric antibiotic therapy. Infect Drug Resist 2018; 11: 2141-2150.
26. Cilloniz C, Martin-Loeches I, Garcia-Vidal C, San Jose A, Torres A. Microbial etiology of pneumonia: epidemiology, diagnosis and resistance patterns. Int J Mol Sci 2016; 17: 2120.
27. Cillóniz C, Ewig S, Polverino E, Marcos MA, Esquinas C, Gabarrús A, et al. Microbial aetiology of community-acquired pneumonia and its relation to severity. Thorax 2011; 66: 340-346.
28. Hashemi SH, Soozanchi G, Jamal-Omidi S, Yousefi-Mashouf R, Mamani M, Seif-Rabiei M-A. Bacterial aetiology and antimicrobial resistance of community-acquired pneumonia in the elderly and younger adults. Trop Doct 2010; 40: 89-91.
29. Regasa B, Yilma D, Sewunet T, Beyene G. Antimicrobial susceptibility pattern of bacterial isolates from community-acquired pneumonia patients in Jimma University specialized hospital, Jimma, Ethiopia. Saudi J Health Sci 2015; 4: 59-64.
30. Temesgen D, Bereded F, Derbie A, Biadglegne F. Bacteriology of community acquired pneumonia in adult patients at Felege Hiwot Referral Hospital, Northwest Ethiopia: a cross-sectional study. Antimicrob Resist Infect Control 2019; 8: 101.
31. Para RA, Fomda BA, Jan RA, Shah S, Koul PA. Microbial etiology in hospitalized North Indian adults with community-acquired pneumonia. Lung India 2018; 35: 108-115.
32. Bjarnason A, Westin J, Lindh M, Andersson L-M, Kristinsson KG, Löve A, et al. Incidence, etiology, and outcomes of community-acquired pneumonia: a population-based study. Open Forum Infect Dis 2018; 5: ofy010.
33. Chi H, Huang Y-C, Liu C-C, Chang K-Y, Huang Y-C, Lin H-C, et al. Characteristics and etiology of hospitalized pediatric community-acquired pneumonia in Taiwan. J Formos Med Assoc 2020; 119: 1490-1499.
34. Luan Y, Sun Y, Duan S, Zhao P, Bao Z. Pathogenic bacterial profile and drug resistance analysis of community-acquired pneumonia in older outpatients with fever. J Int Med Res 2018; 46: 4596-4604.
35. Costa M, Cipriano A, Santos F, Valdoleiros S, Furtado I, Machado A, et al. Clinical profile and microbiological aetiology diagnosis in adult patients hospitalized with community-acquired pneumonia. Pulmonology 2022; 28: 358-367.
36. Blejan IE, Diaconu CC, Letiția A, Arsene DIU, Ghica M, Drăgănescu D, et al. Antibiotic resistance in community-acquired pneumonia. A Romanian perspective. FARMACIA 2020; 68: 512-520.
Files
IssueVol 15 No 3 (2023) QRcode
SectionOriginal Article(s)
DOI https://doi.org/10.18502/ijm.v15i3.12894
Keywords
Community-acquired pneumonia; Pathogenic bacteria; Antibiotic susceptibility pattern
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Hassanzadeh S, Khoramrooz SS, Mazloomirad F, Sharifi A, Roustaei N, Gholamnezhad M, Jamshidnejad E. Bacterial profile and their antimicrobial resistance patterns among patients with community‑acquired pneumonia in southwestern Iran. Iran J Microbiol. 2023;15(3):343-349.